Ziprasidone related compound B
CAS: 1159977-56-6
Ref. 3D-JWB97756
1mg | Discontinued | ||
2mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued |
Product Information
Ziprasidone related compound B is a heterocyclic, nitro-containing, accessing-mediated benzyl n-oxide carboxamide. It has been shown to have antiviral properties that are mediated by the nitro group. Covid-19 is an influenza pandemic in which Ziprasidone related compound B was found to be effective against the virus. The molecular weight of this drug is 416.5 g/mol and it is composed of c1-c3 alkenyl and covid-19 cyclic amines with a benzyl group. This drug also has magnetic properties, which allows for its easy separation from other compounds.